PanTheryx’s Product, DiaResQ, Selected as a Leading Healthcare
Innovation with Great Promise to Transform Global Health

July 16, 2015 08:00 AM Eastern Daylight Time

BOULDER, Colo.--(BUSINESS WIRE)--PanTheryx,
Inc., a global medical nutrition company based in Boulder, Colorado,
announced today its flagship product for pediatric infectious diarrhea, DiaResQ, has
been selected in Reimagining
Global Health, the inaugural report of the Innovation Countdown
2030 initiative, as one of the 30 leading healthcare innovations with
great promise to transform global health by 2030 and to help accelerate
progress toward the new health targets proposed in the United Nations
Sustainable Development Goals.

DiaResQ was one of only 12 innovations recognized in the maternal,
newborn and child health categories. Specifically formulated for the
dietary needs of children with infectious diarrhea, DiaResQ is a
nutritional intervention that promotes intestinal repair and boosts a
child’s natural defenses.

“We are truly honored to have DiaResQ included in the Innovation
Countdown 2030’s Reimagining Global Health report,” said Mark A.
Braman, President and CEO of PanTheryx. “This recognition validates what
we have always believed –that DiaResQ is truly a breakthrough
nutritional intervention for pediatric diarrhea with the potential to
greatly improve the wellbeing and quality of life of millions of
children and their families worldwide.”

Infectious diarrhea is a major world health challenge. Globally,
approximately 1.7 billion cases occur annually in children under five.
Almost 760,000 of these children under five die every year as a result
of this condition. Pediatric infectious diarrhea kills nearly as many
children as HIV/AIDS, malaria and measles combined.

Led by PATH
and supported by the Norwegian Agency for Development Cooperation
(Norad), the Bill & Melinda Gates Foundation, and the United States
Agency for International Development (USAID), the Innovation Countdown
2030 initiative aims to accelerate high-potential innovations,
catalyzing investment and increasing awareness of and support for
transformative ideas to improve health and save lives.

The Innovation Countdown initiative asked 5,000 plus experts, innovators
and technology developers to identify lifesaving ideas and technologies.
Over 500 innovations from more than 50 countries were nominated in eight
categories. The nominations were then qualitatively assessed based upon
the accessibility and affordability of the innovation, stage of
development, expected performance compared to existing solutions,
potential impact, and the number of nominations received. Of the 500
nominated innovations, 175 were then submitted to panels of
world-renowned health area experts for evaluation and ranking. Of these
175, the top 61 were then submitted to a second independent,
interdisciplinary expert panel for final ranking of the top 30
innovations.

Founded in 2007, PanTheryx is a global medical nutrition company based
in Boulder, Colorado, and is dedicated to improving global health and
quality of life through innovative life science. Utilizing its
broad-based proprietary technology platform, PanTheryx is focused on the
research, development and commercialization of medical nutrition
products targeting the gastrointestinal microbiome. The company’s lead
product addresses acute infectious diarrhea, a leading cause of death
worldwide among children under the age of five. For more information,
log on to: www.pantheryx.com
and www.diaresq.com.